Corneal Opacity Induced by Antiglaucoma Agents Other Than Brimonidine Tartrate

Figure 1

Corneal findings in the right (a, c, and e) and left (b, d, and f) eyes. (a, b) Slit-lamp examination shows corneal sterile infiltration and neovascularization in the temporal-lower side of the right eye and in the nasal-lower side of the left eye at the initial visit. (c, d) Two weeks after the initial visit (after topical agents were discontinued and replaced with betamethasone), slit-lamp examination showed a marked regression of the corneal vascularization and decreased corneal opacity bilaterally, while the area of the corneal opacity remained unchanged. (e, f) Six weeks after the initial visit, corneal opacity, intermixed with separate transparent sections, was clearly seen bilaterally, while the area of the corneal opacity remained unchanged.

(a)

(b)

(c)

(d)

(e)

(f)